These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20818488)

  • 1. Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss.
    Jankun J; Keck R; Selman SH; Skrzypczak-Jankun E
    Int J Mol Med; 2010 Oct; 26(4):501-4. PubMed ID: 20818488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very long half-life plasminogen activator inhibitor type 1 reduces bleeding in a mouse model.
    Jankun J; Selman SH; Keck RW; Łysiak-Szydłowska W; Skrzypczak-Jankun E
    BJU Int; 2010 May; 105(10):1469-76. PubMed ID: 19912209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor with very long half-life (VLHL PAI-1) can reduce bleeding in PAI-1-deficient patients.
    Jankun J; Skrzypczak-Jankun E
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):144-50. PubMed ID: 23988002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of long-acting VLHL PAI-1 during sutureless partial nephrectomy in mice reduces bleeding.
    Shahrour K; Keck R; Jankun J
    Biomed Res Int; 2015; 2015():392862. PubMed ID: 25883959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the clot-protecting activity of a mutant plasminogen activator inhibitor-1 with a very long half-life and 6-aminocaproic acid.
    Kindell DG; Keck RW; Jankun J
    Exp Ther Med; 2015 Jun; 9(6):2339-2343. PubMed ID: 26136983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated thrombus lysis in the blood of plasminogen activator inhibitor deficient mice is inhibited by PAI-1 with a very long half-life.
    Jankun J; Aleem AM; Struniawski R; Lysiak-Szydłowska W; Selman SH; Skrzypczak-Jankun E
    Pharmacol Rep; 2009; 61(4):673-80. PubMed ID: 19815949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.
    Pant A; Kopec AK; Baker KS; Cline-Fedewa H; Lawrence DA; Luyendyk JP
    Am J Pathol; 2018 May; 188(5):1204-1212. PubMed ID: 29454747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure.
    Jankun J; Yang J; Zheng H; Han FQ; Al-Senaidy A; Skrzypczak-Jankun E
    Int J Mol Med; 2012 Jan; 29(1):61-4. PubMed ID: 21947232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
    Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
    Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
    Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
    Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
    Hijazi N; Abu Fanne R; Abramovitch R; Yarovoi S; Higazi M; Abdeen S; Basheer M; Maraga E; Cines DB; Higazi AA
    Blood; 2015 Apr; 125(16):2558-67. PubMed ID: 25673638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four cases of bleeding diathesis in children due to congenital plasminogen activator inhibitor-1 deficiency.
    Minowa H; Takahashi Y; Tanaka T; Naganuma K; Ida S; Maki I; Yoshioka A
    Haemostasis; 1999; 29(5):286-91. PubMed ID: 10754381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
    Moore EE; Moore HB; Gonzalez E; Sauaia A; Banerjee A; Silliman CC
    Transfusion; 2016 Apr; 56 Suppl 2(Suppl 2):S110-4. PubMed ID: 27100746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-acting PAI-1 inhibitor reduces thrombus formation.
    Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
    Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.
    Reilly CF; Fujita T; Mayer EJ; Siegfried ME
    Arterioscler Thromb; 1991; 11(5):1276-86. PubMed ID: 1911713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
    Singh S; Houng A; Reed GL
    Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis.
    Urano T; Suzuki Y; Iwaki T; Sano H; Honkura N; Castellino FJ
    Curr Drug Targets; 2019; 20(16):1695-1701. PubMed ID: 31309890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.